← Back to front page
United States · Platforms & data · Benzinga

Helus Pharma Touts Positive Data for Depression Drug

Published by Benzinga · United States 47 min ago
Helus Pharma Touts Positive Data for Depression Drug
Benzinga

Detailed summary

Helus Pharma Inc. (NASDAQ:HELP) reported topline results from its pivotal Phase 3 APPROACH trial, showing its novel serotonergic agonist HLP003 rapidly and durably reduced…

Read the full article on Benzinga Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.benzinga.com)

Also worth reading